Literature DB >> 26266994

The impact of pain on systemic rheumatic diseases.

Piercarlo Sarzi-Puttini1, Fabiola Atzeni2, Daniel J Clauw3, Serge Perrot4.   

Abstract

Pain is associated with the different types of rheumatic syndromes because it is often the most troubling symptom of patients affected by any of these diseases. Some risk factors clearly play a major role in the clinical expression of pain and related syndromes, including genetics, age, gender, co-morbidities, traumas and psychological patterns, but there are no specific clinical, laboratory or neuroimaging markers that can indicate why and when a patient's localised pain will become chronic and widespread. Any type of pain must be treated not only appropriately, but also rapidly because the likelihood of developing some form of chronic pain is related to the duration of the peripheral pain stimulus. Chronic pain inevitably has a major impact on patients' quality of life because the loss of function undermines their ability to do everyday activities. Pain can be most effectively treated by carefully selecting various pharmacological and non-pharmacological interventions based on the characteristics of the pain itself, disease factors, psychological coping abilities, and lifestyle.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic pain; Pharmacological and non-pharmacological therapy; Systemic rheumatic diseases

Mesh:

Year:  2015        PMID: 26266994     DOI: 10.1016/j.berh.2015.05.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  6 in total

1.  The association between waiting time and multidisciplinary pain treatment outcomes in patients with rheumatic conditions.

Authors:  Simon Deslauriers; Jean-Sébastien Roy; Sasha Bernatsky; Debbie E Feldman; Anne Marie Pinard; François Desmeules; Mary-Ann Fitzcharles; Kadija Perreault
Journal:  BMC Rheumatol       Date:  2020-10-23

2.  Attitudes of Israeli Rheumatologists to the Use of Medical Cannabis as Therapy for Rheumatic Disorders.

Authors:  Jacob N Ablin; Ori Elkayam; Mary-Ann Fitzcharles
Journal:  Rambam Maimonides Med J       Date:  2016-04-19

3.  Pain rather than self-reported sedentary time explains variation in perceived health and activity limitation in persons with rheumatoid arthritis: a cross sectional study in Sweden.

Authors:  Ingrid Demmelmaier; Pernilla Åsenlöf; Patrick Bergman; Birgitta Nordgren; Christina H Opava
Journal:  Rheumatol Int       Date:  2017-01-25       Impact factor: 2.631

4.  Factors associated with waiting times for persons with rheumatic conditions in multidisciplinary pain treatment facilities.

Authors:  Simon Deslauriers; Jean-Sébastien Roy; Sasha Bernatsky; Debbie E Feldman; Anne Marie Pinard; François Desmeules; Mary-Ann Fitzcharles; Kadija Perreault
Journal:  J Pain Res       Date:  2019-07-30       Impact factor: 3.133

5.  The burden of waiting to access pain clinic services: perceptions and experiences of patients with rheumatic conditions.

Authors:  Simon Deslauriers; Jean-Sébastien Roy; Sasha Bernatsky; Nathan Blanchard; Debbie E Feldman; Anne Marie Pinard; Mary-Ann Fitzcharles; François Desmeules; Kadija Perreault
Journal:  BMC Health Serv Res       Date:  2021-02-18       Impact factor: 2.655

Review 6.  Diagnostic confounders of chronic widespread pain: not always fibromyalgia.

Authors:  Winfried Häuser; Serge Perrot; Claudia Sommer; Yoram Shir; Mary-Ann Fitzcharles
Journal:  Pain Rep       Date:  2017-04-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.